Effect of a New Interactive Device on the Motor and Functional Abilities of Children With Bilateral Cerebral Palsy
NCT ID: NCT04403464
Last Updated: 2022-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2020-05-26
2022-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, the study aims to investigate the efficiency of using a virtual reality tool to provide a motor skill learning intervention in a randomized trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementation of a New Motor Skill Learning Therapeutic Device in Children With Cerebral Palsy Rehabilitation
NCT03930836
Evaluation of Functional, Neuroplastic and Biomechanical Changes Induced by an Intensive, Playful Early-morning Treatment Including Lower Limbs (EARLY-HABIT-ILE) in Preschool Children With Uni and Bilateral Cerebral Palsy
NCT04017871
Effect of HABIT-ILE on Visuo-spatial Attention of Children With Unilateral CP
NCT02946086
Efficacy Study of an Interactive Robot for the Rehabilitation of the Upper Limb in Children With Cerebral Palsy
NCT01700153
HABIT-ILE in Infants and Toddlers With Cerebral Palsy (Baby HABIT-ILE)
NCT04698395
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore, the study aims to investigate the effects of intensive interventions with or without the interface on the motor and functional abilities of children with bilateral CP.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HABIT-ILE with REAtouch®
Hand and Arm Bimanual Intensive Therapy Including Lower Extremities with an interactive device
HABIT-ILE with REAtouch®
65h HABIT-ILE including 30h REAtouch®
HABIT-ILE without REAtouch®
Hand and Arm Bimanual Intensive Therapy Including Lower Extremities
HABIT-ILE without REAtouch®
65h HABIT-ILE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HABIT-ILE with REAtouch®
65h HABIT-ILE including 30h REAtouch®
HABIT-ILE without REAtouch®
65h HABIT-ILE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MACS levels from I to III,
* GMFCS levels from I to III,
* Ability to follow instructions and complete testing.
Exclusion Criteria
* Unstable seizure
* Severe visual or cognitive impairments likely to interfere with intervention or testing session completion
5 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université Catholique de Louvain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yannick Bleyenheuft
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yannick Bleyenheuft, Professor
Role: PRINCIPAL_INVESTIGATOR
Institute of Neuroscience, UCLouvain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Neuroscience, UCLouvain
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B403201316810e
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.